Antimicrobial activity of aqueous Yerba Mate extracts

Ilex paraguariensis, is used in the preparation of a widely popular tea beverage (Yerba Mate) mainly produced and consumed in the countries of Uruguay, Paraguay, Argentina and Brazil. Dialyzed aqueous extracts were screened for antimicrobial activity against Escherichia coli O157:H7, Staphylococcus aureus, methicillin-resistant S. aureus and S. pseudintermedius, and Pseudomonas syringae pv. tomato. Using a concentrated extract, S. aureus was found to be the more sensitive to extracts than E. coli O157:H7. Minimum inhibitory concentration (MIC) was defined as the lowest concentration of extract tested that did not allow bacterial growth (inhibition) above the original inoculums of approximately 5.0-6.0 log CFU/ml after 24 hr. The minimum bactericidal concentration (MBC) was defined as the lowest concentration tested where bacterial death (inactivation) was observed after 24 hr. MBCs were determined to be ca. 0.150- 0.800 mg protein equivalent/ml and 0.025-0.050 mg protein equivalent/ml against E. coli O157:H7 and S. aureus respectively. Using a lyophilized extract, MICs were determined to be 5 mg/ml for two strains of E. coli O157:H7 and MBCs 5 mg/ml for E. coli O157:H7 strain ATCC 43894 and 10 mg/ml for E. coli O157:H7 strain ‘Cider’ in microbiological media. An approximately \u3e4.5 log reduction was observed for E. coli O157:H7 treated with 40 mg/ml extract in modified apple juice, which approximate to the requirements of the United States Code of Federal Regulations (21 CFR part 120). We demonstrated antimicrobial effectiveness of aqueous extracts after 24 hr at 1 and 2 mg/ml against all strains of methicillin-resistant S. pseudintermedius and of S. aureus tested respectively. An approximately \u3e5 log reduction was observed in all strains at all concentrations after 24 hr. Methicllin-resistant Staphylococcus aureus (MRSA) strains appeared more susceptible to the extract than methicillin-resistant Staphylococcus pseudintermedius (MSRP) strains. It was concluded that aqueous extracts of Yerba Mate demonstrated broad activity against foodborne, human, animal and plant pathogenic bacteria, including strains demonstrating resistance to certain antibiotics

Antimicrobial Activity of Trypsin and Pepsin Hydrolysates Derived From Acid-Precipitated Bovine Casein

Foodborne pathogens are a major concern to the food industry and consumers but they may be controlled with antimicrobials. Naturally occurring antimicrobials may be isolated from a variety of plant, animal and microbial sources. Previous studies have demonstrated that peptides isolated from enzyme hydrolyzed milk proteins may have in vivo and in vitro antimicrobial activity. Such compounds could be of use as inhibitors of foodborne pathogens. The objectives of this study were to determine the antimicrobial effectiveness against Salmonella Typhimurium and Listeria monocytogenes of digests of bovine acid-precipitated casein with the enzymes pepsin and trypsin and to determine if these peptides were effective in combination with ethylendiaminetetraacetic acid (EDTA) and sodium lactate against these foodborne pathogens. Whole casein was precipitated from fresh, unpasteurized skimmed cow’s milk by addition of 2 N HCl. Precipitated casein was separated by centrifugation, washed and lyophilized. Rehydrated casein was hydrolyzed with either pepsin or trypsin and the reaction mixture was heated to inactivate each enzyme. For method 1, solutions with hydrolyzed protein were dialyzed against water and freeze-dried. For method 2, 5.0% casein was dissolved in buffer and treated similarly to method 1, however the peptides that were created from enzymatic hydrolysis were separated by centrifugation after inactivation of the enzymes by heat and were not dialyzed against water. For both methods, hydrolysates created were adjusted to pH 7 and filter sterilized through a 0.45 mm membrane filter The inhibitory effect of filtered pepsin and trypsin hydrolysates (0.5% and 1.0%) (method 1) and filtered supernate (pepsin and trypsin) (method 2) alone and in combination with EDTA and sodium lactate against four strains each of L. monocytogenes and S. Typhimurium DT104 was determined. Growth was monitored over 24 hours using a microbroth dilution assay for all hydrolysates. Growth curves were used to relate microtiter data to actual colony counts. For method 1, pepsin hydrolysates were not very effective in inhibiting the growth of any of the four strains of S. Typhimurium or L. monocytogenes while trypsin hydrolysates were only slightly effective at extending the lag phase and/or reducing the final growth level of all four strains of L. monocytogenes. This ineffectiveness was most likely due to the loss of small molecular weight peptides during the dialysis step. The addition of EDTA had little effect in enhancing the inhibitory effect of pepsin or trypsin hydrolysates against either microorganism. For method 2, trypsin hydrolysates were effective in extending the lag phase and/or reducing the final growth level of all four strains of L. monocytogenes tested; however, they were not effective against any of the strains of S. Typhimurium. Pepsin hydrolysate was not effective in extending the lag phase or reducing the final growth level in S. Typhimurium. However, pepsin did reduce the final growth level of one strain of L. monocytogenes, 101. Trypsin and pepsin hydrolysates derived from bovine milk in combination with EDTA and sodium lactate had antimicrobial activity against both L. monocytogenes and S. Typhimurium in tryptic soy broth (TSB). Trypsin hydrolysates also enhanced the antimicrobial activity of sodium lactate against Listeria monocytogenes. The protein concentrations of pepsin and trypsin hydrolysates (before and after membrane filtration) prepared using method 2 was determined with three different protein assays, Bradford dye-binding, modified Lowry and UV 280 nm. For all three methods, non-filtered hydrolysates were higher in protein concentration than those that were filtered. Using the Bradford method, pepsin hydrolysates were higher in protein concentration than trypsin hydrolysates in both filtered and non-filtered samples. The opposite results were observed when using both modified Lowry method and UV 280 nm method to determine protein concentration. By examining the location of the peptide bond hydrolysis of the enzymes, it was possible to determine that small molecular weight peptides were created by the addition of trypsin and pepsin to bovine casein. Variation in number of amino acids as well as types of amino acids of peptides created during hydrolysis likely influenced the antimicrobial effectiveness of each hydrolysate. Casein-derived peptides could provide an alternative or adjunct to antimicrobials currently used in foods. It is suggested that antimicrobial peptides can be created by enzymatic hydrolysis of casein with trypsin and these peptides have the potential to serve as antimicrobials in food systems. Further research needs to be conducted in enhancing the activity by concentrating the hydrolysates or isolating and characterizing those peptides with the greatest antimicrobial potential

Horizontal Gene Transfer to Bacteria of an Arabidopsis Thaliana ABC Transporter That Confers Kanamycin Resistance in Transgenic Plants

The use of antibiotic resistance markers is an important tool in the production and selection of transgenic plants. There have been increased concerns about the potential horizontal gene transfer (HGT) from transgenic plants to bacteria of medical and environmental importance. Until recently all antibiotic resistance genes used in transgenic studies have been bacterial in origin. An Arabidopsis thaliana ABC transporter, Atwbc19, was the first plant gene shown to confer kanamycin resistance when overexpressed in transgenic plants. The Atwbc19 gene was evaluated for its ability to transfer antibiotic resistance to Escherichia coli, which are found in the human gut and environment. Simulated HGT was staged by subcloning Atwbc19 under the control of a bacterial promoter, genetically transforming the bacteria and assessing if resistance was conferred as compared to the same treatment of the E. coli nptII gene. The nptII gene provided greater resistance to kanamycin in E. coli than that of the Atwbc19 gene and was significantly different from the no-plasmid control at higher concentrations of kanamycin (e.g., over 10 mg L -1) (p \u3c 0.05). The Atwbc19 gene was not significantly different from the no-plasmid control at higher concentrations of kanamycin (e.g., over 25 mg L -1) (p \u3c 0.05). E. coli transformed with Atwbc19 conferred little resistance to kanamycin at 100 mg L-1. Results from Northern gel blot analysis indicated that expression levels for nptII were similar to that of Atwbc19 for the two concentrations of the antibiotic kanamycin tested. However, there was a slightly apparent decrease in the level of expression for Atwbc19 compared to the nptII gene that was most likely the result to the plant codon usage of the ABC gene or its large size (over two-fold greater than nptII). This research supports the use of the Atwbc19 gene in transgenic plants as a selectable marker and potential replacement of the nptII gene for kanamycin selection systems

The Vehicle, Fall 1994

Table of Contents Poetry Noah\u27s WifeJennifer Moropage 8-9 The Intensity of a BreathHeather Anne Winterspage 10-11 When I Was RainNicole Moonpage 11 Wreckage at Low Tide, After a Storm On Cape FearMatt Parkspage 12-14 two belowKeith Spearpage 16 HeatScott Langrenpage 17 Plastic Shard WordsMatthew J. Nelsonpage 18 Mr. Snowplow ManMartin Paul Brittpage 19 Carpe DiemMichael Lairpage 19 untitledWalt Howardpage 20 The GameKellie J. Olsenpage 21 AT PEACEJennifer Surmanpage 22 SawdustSue Songerpage 23 Photography Unbound RealitiesKris Quiriconipage 26 untitled Mark Porter page 27 untitled Mark Porter page 28 untitled Mark Porter page 29 Prose I am Here...RememberingJ. Dylan McNeillpage 32-34 RecognitionSue Songerpage 35-36 SACCADICSteve Beinpage 37-40 The BurnBryan Levekpage 41-45 Biographiespage 46-48https://thekeep.eiu.edu/vehicle/1063/thumbnail.jp

The Vehicle, Fall 1994

Table of Contents Poetry Noah\u27s WifeJennifer Moropage 8-9 The Intensity of a BreathHeather Anne Winterspage 10-11 When I Was RainNicole Moonpage 11 Wreckage at Low Tide, After a Storm On Cape FearMatt Parkspage 12-14 two belowKeith Spearpage 16 HeatScott Langrenpage 17 Plastic Shard WordsMatthew J. Nelsonpage 18 Mr. Snowplow ManMartin Paul Brittpage 19 Carpe DiemMichael Lairpage 19 untitledWalt Howardpage 20 The GameKellie J. Olsenpage 21 AT PEACEJennifer Surmanpage 22 SawdustSue Songerpage 23 Photography Unbound RealitiesKris Quiriconipage 26 untitled Mark Porter page 27 untitled Mark Porter page 28 untitled Mark Porter page 29 Prose I am Here...RememberingJ. Dylan McNeillpage 32-34 RecognitionSue Songerpage 35-36 SACCADICSteve Beinpage 37-40 The BurnBryan Levekpage 41-45 Biographiespage 46-48https://thekeep.eiu.edu/vehicle/1063/thumbnail.jp

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Discordance Between Cobas BRAF V600 Testing and VE1 Immunohistochemistry in a Melanoma Patient With Bone Marrow Metastases.

False negative result remains an ongoing problem in direct gene sequencing of cancers. It is important to use the appropriate mutation detection method most appropriate to each circumstance and the available tissue. Here, we report a patient with melanoma of unknown primary with metastases to spleen and bone marrow, who was tested negative for Cobas BRAF V600E mutation, whose cancer progressed on antiprogrammed death 1 (PD1) receptor monoclonal antibody therapy. Subsequent VE1 immunohistochemistry was positive for BRAF V600E mutation, and the tumor responded dramatically to v-Raf murine sarcoma viral oncogene homolog B (BRAF)/Mitogen-activated protein kinase inhibitor combination therapy. This demonstrates how alternative BRAF testing methodology could produce results that can influence treatment choice and the outcome